| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 0 | 4.234 | 1.983 | 0 |
| Total Income - EUR | - | - | - | 0 | 0 | 0 | 0 | 12.715 | 3.233 | 0 |
| Total Expenses - EUR | - | - | - | 624 | 2.335 | 2.114 | 1.913 | 5.607 | 7.893 | 5.915 |
| Gross Profit/Loss - EUR | - | - | - | -624 | -2.335 | -2.114 | -1.913 | 7.109 | -4.660 | -5.915 |
| Net Profit/Loss - EUR | - | - | - | -624 | -2.335 | -2.114 | -1.913 | 6.982 | -4.673 | -5.915 |
| Employees | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sebi Deea Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.962 | 1.433 | 923 | 432 | 2.155 | 584 | 332 |
| Current Assets | - | - | - | 428 | 166 | 546 | 44 | 9.550 | 7.892 | 2.579 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 37 | 36 |
| Cash | - | - | - | 428 | 166 | 546 | 44 | 9.550 | 7.856 | 2.543 |
| Shareholders Funds | - | - | - | -581 | -2.904 | -4.963 | -6.766 | 195 | -4.478 | -10.368 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.970 | 4.503 | 6.433 | 7.242 | 11.510 | 12.954 | 13.278 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Sebi Deea Med S.r.l.